A PYMNTS Company

US: Rite Aid files antitrust claim against maker of acne drug

By  |  April 16, 2015

Rite Aid Corp. is claiming Medicis Pharmaceutical Corp., the manufacturer of acne treatment drug Solodyn, filed improper petitions and arranged unlawful agreements with their competitors to keep generic versions of Solodyn from reaching the market.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Rite Aid made the claims in an antitrust lawsuit filed in U.S. District Court for the Middle District of Pennsylvania on April 16.

    “Medicis orchestrated a scheme to delay and suppress generic competition with respect to Solodyn and to maintain and extend its monopoly in the market for minocycline hydrochloride extended release tablets, to the detriment of Plaintiffs and other purchasers of the drug,” the suit reads.

     

    Full Content: The Pennsylvania Record

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.